{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:13:54Z","timestamp":1789424034572,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG058501"],"award-info":[{"award-number":["AG058501"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS118227"],"award-info":[{"award-number":["R21NS118227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de recherche du Quebec Sante","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ebiom.2023.104789","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T16:23:40Z","timestamp":1694449420000},"page":"104789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis"],"prefix":"10.1016","volume":"96","author":[{"given":"Hanane","family":"Touil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-8358","authenticated-orcid":false,"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Zuroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cignarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ludwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gommerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick C.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A.","family":"Benjamins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Lisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack P.","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7179-0335","authenticated-orcid":false,"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2023.104789_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104789_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ana.21363","article-title":"Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial","volume":"63","author":"Bar-Or","year":"2008","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104789_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archneurol.2010.99","article-title":"Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis","volume":"67","author":"Piccio","year":"2010","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104789_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1756285612461165","article-title":"Rituximab combination therapy in relapsing multiple sclerosis","volume":"5","author":"Cross","year":"2012","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104789_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104789_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ebiom.2023.104789_bib7","doi-asserted-by":"crossref","first-page":"e1805","DOI":"10.1212\/WNL.0000000000005516","article-title":"Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: the MIRROR study","volume":"90","author":"Bar-Or","year":"2018","journal-title":"Neurology"},{"issue":"53","key":"10.1016\/j.ebiom.2023.104789_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc7191","article-title":"Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis","volume":"5","author":"Probstel","year":"2020","journal-title":"Sci Immunol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104789_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMoa2201904","article-title":"Ublituximab versus teriflunomide in relapsing multiple sclerosis","volume":"387","author":"Steinman","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104789_bib11","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"7492","key":"10.1016\/j.ebiom.2023.104789_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104789_bib13","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104789_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B\u00a0cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J\u00a0Exp Med"},{"issue":"310","key":"10.1016\/j.ebiom.2023.104789_bib15","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104789_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-017-0798-5","article-title":"Activation of human B cells negatively regulates TGF-beta1 production","volume":"14","author":"Molnarfi","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104789_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"issue":"Pt 4","key":"10.1016\/j.ebiom.2023.104789_bib18","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.ebiom.2023.104789_bib19","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","article-title":"Inflammatory cortical demyelination in early multiple sclerosis","volume":"365","author":"Lucchinetti","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1-2","key":"10.1016\/j.ebiom.2023.104789_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneuroim.2011.01.010","article-title":"Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin","volume":"233","author":"Obermeier","year":"2011","journal-title":"J\u00a0Neuroimmunol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B\u00a0cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali","year":"2020","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104789_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151683","article-title":"Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis","volume":"7","author":"Ahmed","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.26448","article-title":"\"Ependymal-in\" gradient of thalamic damage in progressive multiple sclerosis","volume":"92","author":"Magliozzi","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2023.104789_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2015.00636","article-title":"B\u00a0cells in the multiple sclerosis central nervous system: trafficking and contribution to CNS-compartmentalized inflammation","volume":"6","author":"Michel","year":"2015","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104789_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104789_bib26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnen\/62.7.723","article-title":"Subpial demyelination in the cerebral cortex of multiple sclerosis patients","volume":"62","author":"Bo","year":"2003","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A\u00a0Gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"10.1016\/j.ebiom.2023.104789_bib28","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"issue":"1-2","key":"10.1016\/j.ebiom.2023.104789_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","article-title":"Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in\u00a0vitro","volume":"246","author":"Lisak","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ebiom.2023.104789_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","article-title":"B\u00a0cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in\u00a0vitro","volume":"309","author":"Lisak","year":"2017","journal-title":"J\u00a0Neuroimmunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104789_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12974-018-1136-2","article-title":"Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis","volume":"15","author":"Touil","year":"2018","journal-title":"J\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00401-022-02411-w","article-title":"BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy","volume":"143","author":"Li","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104789_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/glia.22298","article-title":"Comparison of polarization properties of human adult microglia and blood-derived macrophages","volume":"60","author":"Durafourt","year":"2012","journal-title":"Glia"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104789_bib34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/glia.21064","article-title":"A\u00a0proteome map of axoglial specializations isolated and purified from human central nervous system","volume":"58","author":"Dhaunchak","year":"2010","journal-title":"Glia"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104789_bib35","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.25197","article-title":"Inflammatory intrathecal profiles and cortical damage in multiple sclerosis","volume":"83","author":"Magliozzi","year":"2018","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104789_bib37","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000550","article-title":"Exosome-enriched fractions from MS B cells induce oligodendrocyte death","volume":"6","author":"Benjamins","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ebiom.2023.104789_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/925135","article-title":"CD4(+)T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"Pt 11","key":"10.1016\/j.ebiom.2023.104789_bib39","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10616-020-00409-4","article-title":"IL-4 and IL-10 promotes phagocytic activity of microglia by up-regulation of TREM2","volume":"72","author":"Yi","year":"2020","journal-title":"Cytotechnology"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104789_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"7878","key":"10.1016\/j.ebiom.2023.104789_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A\u00a0lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104789_bib43","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104789_bib44","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104789_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2021-000240","article-title":"Chronic lesion activity and disability progression in secondary progressive multiple sclerosis","volume":"4","author":"Beynon","year":"2022","journal-title":"BMJ Neurol Open"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104789_bib46","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1177\/13524585221102921","article-title":"Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: a retrospective cross-sectional study","volume":"28","author":"Hemond","year":"2022","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104789_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4049\/jimmunol.1401156","article-title":"Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation","volume":"194","author":"Moore","year":"2015","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104789_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay6324","article-title":"Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion","volume":"6","author":"Plemel","year":"2020","journal-title":"Sci Adv"},{"issue":"15","key":"10.1016\/j.ebiom.2023.104789_bib49","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.1948-20.2021","article-title":"Harnessing the benefits of neuroinflammation: generation of macrophages\/microglia with prominent remyelinating properties","volume":"41","author":"Mishra","year":"2021","journal-title":"J\u00a0Neurosci"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104789_bib50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","article-title":"Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke","volume":"54","author":"Shi","year":"2021","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.ebiom.2023.104789_bib51","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/j.neuron.2022.06.023","article-title":"Microglia in multiple sclerosis: protectors turn destroyers","volume":"110","author":"Yong","year":"2022","journal-title":"Neuron"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:23:34Z","timestamp":1762457014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423003559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":51,"alternative-id":["S2352396423003559"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104789","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104789"}}